- Home
- MDXH vs MBOT Comparison
MDXH vs MBOT Comparison
Compare MDXH & MBOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MDXH
- MBOT
- Stock Information
- Founded
- MDXH 2003
- MBOT 2010
- Country
- MDXH Belgium
- MBOT United States
- Employees
- MDXH N/A
- MBOT N/A
- Industry
- MDXH
- MBOT Medical/Dental Instruments
- Sector
- MDXH
- MBOT Health Care
- Exchange
- MDXH Nasdaq
- MBOT Nasdaq
- Market Cap
- MDXH 84.6M
- MBOT 94.6M
- IPO Year
- MDXH 2021
- MBOT N/A
- Fundamental
- Price
- MDXH $2.44
- MBOT $2.50
- Analyst Decision
- MDXH Buy
- MBOT Strong Buy
- Analyst Count
- MDXH 1
- MBOT 1
- Target Price
- MDXH $6.00
- MBOT $9.00
- AVG Volume (30 Days)
- MDXH 54.9K
- MBOT 1.1M
- Earning Date
- MDXH 08-20-2025
- MBOT 08-13-2025
- Dividend Yield
- MDXH N/A
- MBOT N/A
- EPS Growth
- MDXH N/A
- MBOT N/A
- EPS
- MDXH N/A
- MBOT N/A
- Revenue
- MDXH $94,507,000.00
- MBOT N/A
- Revenue This Year
- MDXH $23.51
- MBOT N/A
- Revenue Next Year
- MDXH $17.68
- MBOT N/A
- P/E Ratio
- MDXH N/A
- MBOT N/A
- Revenue Growth
- MDXH 25.46
- MBOT N/A
- 52 Week Low
- MDXH $1.35
- MBOT $0.82
- 52 Week High
- MDXH $3.50
- MBOT $3.38
- Technical
- Relative Strength Index (RSI)
- MDXH 64.50
- MBOT 49.35
- Support Level
- MDXH $2.17
- MBOT $2.39
- Resistance Level
- MDXH $2.35
- MBOT $2.59
- Average True Range (ATR)
- MDXH 0.07
- MBOT 0.14
- MACD
- MDXH 0.01
- MBOT -0.00
- Stochastic Oscillator
- MDXH 96.90
- MBOT 31.58
About MDXH MDxHealth SA
MDxHealth SA is a multinational healthcare company that provides actionable molecular diagnostic information to personalize the diagnosis and treatment of cancer. Its tests are based on proprietary genomic, epigenetic, and other molecular technologies and assist physicians with the diagnosis of urologic cancers, the prognosis of recurrence risk, and the prediction of response to a specific therapy. It derives revenues from clinical laboratory service testing or the out-licensing of the company's patented DNA methylation platform and biomarkers. Geographically, it derives revenue from the United States of America (USA) and Europe.
About MBOT Microbot Medical Inc.
Microbot Medical Inc is a clinical-stage medical device company specializing in the research, design and development of next-generation robotic endoluminal surgery devices targeting the minimally invasive surgery space. It is focused on leveraging its robotic technologies to redefine surgical robotics while improving surgical outcomes for patients. Using its LIBERTY technological platform, the company is developing the first-ever fully disposable robot for various endovascular interventional procedures.